- Home
- JZ vs VOR Comparison
JZ vs VOR Comparison
Compare JZ & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- VOR
- Stock Information
- Founded
- JZ 2011
- VOR 2015
- Country
- JZ China
- VOR United States
- Employees
- JZ N/A
- VOR N/A
- Industry
- JZ Other Consumer Services
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- JZ Real Estate
- VOR Health Care
- Exchange
- JZ Nasdaq
- VOR Nasdaq
- Market Cap
- JZ 26.7M
- VOR 22.1M
- IPO Year
- JZ 2022
- VOR 2021
- Fundamental
- Price
- JZ $1.62
- VOR $0.89
- Analyst Decision
- JZ
- VOR Buy
- Analyst Count
- JZ 0
- VOR 7
- Target Price
- JZ N/A
- VOR $6.07
- AVG Volume (30 Days)
- JZ 261.3K
- VOR 30.9M
- Earning Date
- JZ 09-27-2024
- VOR 08-07-2025
- Dividend Yield
- JZ N/A
- VOR N/A
- EPS Growth
- JZ N/A
- VOR N/A
- EPS
- JZ N/A
- VOR N/A
- Revenue
- JZ $34,090,704.00
- VOR N/A
- Revenue This Year
- JZ N/A
- VOR N/A
- Revenue Next Year
- JZ N/A
- VOR N/A
- P/E Ratio
- JZ N/A
- VOR N/A
- Revenue Growth
- JZ N/A
- VOR N/A
- 52 Week Low
- JZ $1.60
- VOR $0.13
- 52 Week High
- JZ $14.60
- VOR $1.80
- Technical
- Relative Strength Index (RSI)
- JZ 21.61
- VOR 87.39
- Support Level
- JZ $1.72
- VOR $0.29
- Resistance Level
- JZ $2.15
- VOR $0.23
- Average True Range (ATR)
- JZ 0.46
- VOR 0.11
- MACD
- JZ -0.04
- VOR 0.07
- Stochastic Oscillator
- JZ 1.09
- VOR 65.71
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.